VS3 Medical gets FDA breakthrough device designation

The U.S. Food and Drug Administration granted Breakthrough Device Designation to VS3 Medical’s VS3 System for treating debilitating pulsatile tinnitus. The company said the investigational device is designed to address venous sinus stenosis.